1. Jesus D, Matos A, Henriques C, et al. Derivation and validation of the SLE Disease Activity Score (SLE-DAS): a new SLE continuous measure with high sensitivity for changes in disease activity. Ann Rheum Dis 2019; 78: 365-71. doi: 10.1136/annrheumdis-2018-214502
2. Jesus D, Matos A, Henriques C, et al. Response to: 'SLE-DAS: ready for routine use' by Mathew et al. Ann Rheum Dis 2019. doi: 10.1136/annrheumdis-2019-215794.
3. Jesus D, Matos A, Henriques C, et al. Response to: 'Performance of the systemic lupus erythematosus disease activity score (SLE-DAS) in a Latin American population', by Rodriguez-Gonzalez et al. Ann Rheum Dis 2019. doi: 10.1136/annrheumdis-2019-216110.
4. Jesus D, Zen M, Doria A, et al. Response to: 'Assessment of responsiveness of the musculoskeletal component of SLE-DAS in an independent cohort', by Hassan et al. Ann Rheum Dis 2019. doi: 10.1136/annrheumdis-2019-215430
5. Jesus D, Matos A, Henriques C, et al. FRI0641 Detection of changes in SLE disease activity is highly improved with SLE-DAS as compared to SLEDAI: derivation and preliminary validation of the sle disease activity score (SLE-DAS). Ann Rheum Dis 2018; 77: 842-3. doi: 10.1136/annrheumdis-2018-eular.3161
Systemic lupus erythematosus disease activity state (SLE-DAS) is a validated 17-item composite index with continuous measurement properties for lupus disease activity assessment [1-5]. In external validation, as compared to SLEDAI-2K, SLE-DAS presented higher accuracy in measuring SLE disease activity, better sensitivity to detect a clinically meaningful change, as well as higher performance in predicting damage accrual .